| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |